Chemosensitization prevents tolerance of Aspergillus fumigatus to antimycotic drugs

Biochemical and Biophysical Research Communications

Volumn 372, Issue 1, 2008, Pages 266-271

  Kim, Jong ^a   Campbell, Bruce ^a   Mahoney, Noreen ^a   Chan, Kathleen ^a   Molyneux, Russell ^a   May, Gregory ^b  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antifungal chemotherapy; Aspergillus fumigatus; Chemosensitization; Combination therapy; MAPK; Natural compounds

Indexed keywords

2,3 DIHYDROXYBENZALDEHYDE; 2,5 DIHYDROXYBENZALDEHYDE; ACETYLSALICYLIC ACID; AMPHOTERICIN B; BENZALDEHYDE DERIVATIVE; BENZOIC ACID; BERBERINE DERIVATIVE; BERBERINE HEMISULFATE; CERCOSPORAMIDE; CINNAMIC ACID; COUMARIC ACID; ECHINOCANDIN; FLUCONAZOLE; GENTISIC ACID; KETOCONAZOLE; PROTEIN KINASE C INHIBITOR; SALICYLIC ACID; THYMOL;

ALTERNATIVE MEDICINE; ARTICLE; ASPERGILLUS FUMIGATUS; CELL WALL; CHEMOSENSITIZATION; CONTROLLED STUDY; DRUG USE; FUNGAL STRAIN; MYCOSIS; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BENZALDEHYDES; CATECHOLS; CELL MEMBRANE; CELL WALL; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; GENE DELETION; HUMANS; KETOCONAZOLE; MICROBIAL SENSITIVITY TESTS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATIVE STRESS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SORBITOL; THYMOL;

ASPERGILLUS FUMIGATUS; FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 46349095613     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.05.030     Document Type: Article

References (30)

1. Jiang B., Ram A.F., Sheraton J., Klis F.M., and Bussey H. Regulation of cell wall beta-glucan assembly: PTC1 negatively affects PBS2 action in a pathway that includes modulation of EXG1 transcription. Mol. Gen. Genet. 248 (1995) 260-269
2. Lai M.H., Silverman S.J., Gaughran J.P., and Kirsch D.R. Multiple copies of PBS2, MHP1 or LRE1 produce glucanase resistance and other cell wall effects in Saccharomyces cerevisiae. Yeast 13 (1997) 199-213
3. García-Rodriguez L.J., Durán A., and Roncero C. Calcofluor antifungal action depends on chitin and a functional high-osmolarity glycerol response (HOG) pathway: evidence for a physiological role of the Saccharomyces cerevisiae HOG pathway under noninducing conditions. J. Bacteriol. 182 (2000) 2428-2437
4. Alonso-Monge R., Navarro-García F., Molero G., Diez-Orejas R., Gustin M., Pla J., Sanchez M., and Nombela C. Role of the mitogen-activated protein kinase Hog1p in morphogenesis and virulence of Candida albicans. J. Bacteriol. 181 (1999) 3058-3068
5. Kojima K., Takano Y., Yoshimi A., Tanaka C., Kikuchi T., and Okuno T. Fungicide activity through activation of a fungal signalling pathway. Mol. Microbiol. 53 (2004) 1785-1796
6. Kim J.H., Campbell B.C., Mahoney N., Chan K.L., Molyneux R.J., and May G.S. Enhancement of fludioxonil fungicidal activity by disrupting cellular glutathione homeostasis with 2,5-dihydroxybenzoic acid. FEMS Microbiol. Lett. 270 (2007) 284-290
7. Beauvais A., and Latgé J.P. Membrane and cell wall targets in Aspergillus fumigatus. Drug Resist. Updat. 4 (2001) 38-49
8. Levin D.E., Fields F.O., Kunisawa R., Bishop J.M., and Thorner J. A candidate protein kinase C gene, PKC1, is required for the S. cerevisiae cell cycle. Cell 62 (1990) 213-224
9. Fujioka T., Mizutani O., Furukawa K., Sato N., Yoshimi A., Yamagata Y., Nakajima T., and Abe K. MpkA-Dependent and -independent cell wall integrity signaling in Aspergillus nidulans. Eukaryot. Cell 6 (2007) 1497-1510
10. Xue T., Nguyen C.K., Romans A., and May G.S. A mitogen-activated protein kinase that senses nitrogen regulates conidial germination and growth in Aspergillus fumigatus. Eukaryot. Cell 3 (2004) 557-560
11. Reyes G., Romans A., Nguyen C.K., and May G.S. Novel mitogen-activated protein kinase MpkC of Aspergillus fumigatus is required for utilization of polyalcohol sugars. Eukaryot. Cell 5 (2006) 1934-1940
12. Vincent J.M. Distortion of fungal hyphae in the presence of certain inhibitors. Nature 159 (1947) 850
13. National Committee for Clinical Laboratory Standards, Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved standard NCCLS document M38-A, Wayne, PA, Clinical and Laboratory Standards Institute, 2002.
14. Ferreira C., Silva S., van Voorst F., Aguiar C., Kielland-Brandt M.C., Brandt A., and Lucas C. Absence of Gup1p in Saccharomyces cerevisiae results in defective cell wall composition, assembly, stability and morphology. FEMS Yeast Res. 6 (2006) 1027-1038
15. Tucker C.L., and Fields S. Quantitative genome-wide analysis of yeast deletion strain sensitivities to oxidative and chemical stress. Comp. Funct. Genomics 5 (2004) 216-224
16. Tawata S., Taira S., Kobamoto N., Zhu J., Ishihara M., and Toyama S. Synthesis and antifungal activity of cinnamic acid esters. Biosci. Biotechnol. Biochem. 60 (1996) 909-910
17. Park B.J., Park J.C., Taguchi H., Fukushima K., Hyon S.H., and Takatori K. Antifungal susceptibility of epigallocatechin 3- O -gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochem. Biophys. Res. Commun. 347 (2006) 401-405
18. Pinto E., Pina-Vaz C., Salgueiro L., Gonçalves M.J., Costa-de-Oliveira S., Cavaleiro C., Palmeira A., Rodrigues A., and Martinez-de-Oliveira J. Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus and dermatophyte species. J. Med. Microbiol. 55 (2006) 1367-1373
19. Lussier M., White A.M., Sheraton J., di Paolo T., Treadwell J., Southard S.B., Horenstein C.I., Chen-Weiner J., Ram A.F., Kapteyn J.C., Roemer T.W., Vo D.H., Bondoc D.C., Hall J., Zhong W.W., Sdicu A.M., Davies J., Klis F.M., Robbins P.W., and Bussey H. Large scale identification of genes involved in cell surface biosynthesis and architecture in Saccharomyces cerevisiae. Genetics 147 (1997) 435-450
20. Martin H., Rodríguez-Pachón J.M., Ruiz C., Nombela C., and Molina M. Regulatory mechanisms for modulation of signaling through the cell integrity Slt2-mediated pathway in Saccharomyces cerevisiae. J. Biol. Chem. 275 (2000) 1511-1519
21. Roncero C., Valdivieso M.H., Ribas J.C., and Durán A. Isolation and characterization of Saccharomyces cerevisiae mutants resistant to Calcofluor white. J. Bacteriol. 170 (1988) 1950-1954
22. Imai K., Noda Y., Adachi H., and Yoda K. A novel endoplasmic reticulum membrane protein Rcr1 regulates chitin deposition in the cell wall of Saccharomyces cerevisiae. J. Biol. Chem. 280 (2005) 8275-8284
23. Ram A.F., Wolters A., Ten Hoopen R., and Klis F.M. A new approach for isolating cell wall mutants in Saccharomyces cerevisiae by screening for hypersensitivity to calcofluor white. Yeast 10 (1994) 1019-1030
24. Mellado E., Aufauvre-Brown A., Gow N.A., and Holden D.W. The Aspergillus fumigatus chsC and chsG genes encode class III chitin synthases with different functions. Mol. Microbiol. 20 (1996) 667-679
25. Beauvais A., Bruneau J.M., Mol P.C., Buitrago M.J., Legrand R., and Latgé J.P. Glucan synthase complex of Aspergillus fumigatus. J. Bacteriol. 183 (2001) 2273-2279
26. Delom F., Szponarski W., Sommerer N., Boyer J.C., Bruneau J.M., Rossignol M., and Gibrat R. The plasma membrane proteome of Saccharomyces cerevisiae and its response to the antifungal calcofluor. Proteomics 6 (2006) 3029-3039
27. Shvedova A.A., Kommineni C., Jeffries B.A., Castranova V., Tyurina Y.Y., Tyurin V.A., Serbinova E.A., Fabisiak J.P., and Kagan V.E. Redox cycling of phenol induces oxidative stress in human epidermal keratinocytes. J. Invest. Dermatol. 114 (2000) 354-364
28. Jacob C. A scent of therapy: pharmacological implications of natural products containing redox-active sulfur atoms. Nat. Prod. Rep. 23 (2006) 851-863
29. Sussman A., Huss K., Chio L.C., Heidler S., Shaw M., Ma D., Zhu G., Campbell R.M., Park T.S., Kulanthaivel P., Scott J.E., Carpenter J.W., Strege M.A., Belvo M.D., Swartling J.R., Fischl A., Yeh W.K., Shih C., and Ye X.S. Discovery of cercosporamide, a known antifungal natural product, as a selective Pkc1 kinase inhibitor through high-throughput screening. Eukaryot. Cell 3 (2004) 932-943
30. Isenberg H.D. Clinical Microbiology Procedures Handbook (1992), American Society for Microbiology, Washington, D.C.